Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Sex Transm Dis. 2021 Jun 22:10.1097/OLQ.0000000000001503. doi: 10.1097/OLQ.0000000000001503

Table 2:

Sensitivity of self-report of HPV vaccine compared to documented vaccine record among participating men who have sex with men and transgender women — Seattle, Washington, 2016–2018

Self-report responsea
n with documented HPV vaccinationb Yes No Don’t know/no answer Sensitivity % 95% Confidence Interval
Overall 292 243 15 34 83.2 78.4–87.3
Age group
 18–21 years 91 72 7 12 79.1 69.3–86.9
 22–26 years 201 171 8 22 85.1 79.3–89.7
Time since first documented HPV vaccine dose
 <1 year ago 87 77 3 7 88.5 79.9–94.3
 1–2 years ago 94 82 2 10 87.2 78.8–93.2
 ≥3 years ago 112 84 10 18 75.0 65.9–82.7
Documented number of HPV vaccine doses
 1 104 76 12 16 73.1 63.5–81.3
 2 73 63 2 8 86.3 76.2–93.2
 ≥3 115 104 1 10 90.4 83.5–95.1
Documented3 HPV vaccine dosesc 115 80d 8d 27d 69.6d 60.3–77.8d
a

Answer to the survey question, “Have you ever received any vaccine against human papillomavirus (HPV)?” as reported by the participant

b

≥1 dose of HPV vaccine as documented in either the clinic electronic medical records (EMR) or the Washington State Immunization Information System (WAIIS) or both

c

Restricted to those with ≥3 documented vaccine record doses

d

Self-report agreement and sensitivity for self-reporting ≥3 doses of HPV vaccine